![Viking Therapeutics Inc](/common/images/company/N_VKTX.png)
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, ti... Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator. Show more
Ford Motor (NYSE:F) – The global automaker reported adjusted earnings per share of $0.47 in the second quarter, below the $0.67 expected, impacted by ongoing warranty issues. Revenue...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 7.95 | 14.0088105727 | 56.75 | 69.99 | 55.05 | 5151414 | 65.19171956 | CS |
4 | -0.92 | -1.40201158183 | 65.62 | 70.96 | 47.31 | 3917378 | 60.16369301 | CS |
12 | 2.42 | 3.8856775851 | 62.28 | 70.96 | 46.11 | 3862900 | 56.93306915 | CS |
26 | 28.99 | 81.181741809 | 35.71 | 99.3999 | 35.62 | 5011621 | 69.88614233 | CS |
52 | 50.19 | 345.899379738 | 14.51 | 99.3999 | 8.28 | 3795453 | 52.26014467 | CS |
156 | 58.9 | 1015.51724138 | 5.8 | 99.3999 | 2.02 | 2550660 | 31.44432471 | CS |
260 | 57.75 | 830.935251799 | 6.95 | 99.3999 | 2.02 | 2030764 | 25.23734793 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.